SPDR S&P Pharmaceuticals ETF
XPH
XPH
76 hedge funds and large institutions have $271M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
37% less call options, than puts
Call options by funds: $520K | Put options by funds: $824K
45% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 33
Holders
76
Holding in Top 10
1
Calls
$520K
Puts
$824K
Top Buyers
| 1 | +$25.9M | |
| 2 | +$12.2M | |
| 3 | +$5.5M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.1M |
| 5 |
LPL Financial
San Diego,
California
|
+$3.86M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$13.8M | |
| 3 | -$8.5M | |
| 4 |
Citigroup
New York
|
-$5.23M |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
-$4.6M |